Securities exchange experts and representatives have as of late revised their objective costs on shares of Syneron Medical Ltd. (NASDAQ:ELOS).
The latest expert appraisals issued by businesses:
08/05/2016 – Syneron Medical Ltd. was downsized to "market perform" by examiners at Leerink Swann. They now have a USD 7.8 value focus on the stock.
05/31/2016 – Syneron Medical Ltd. had its "purchase" rating repeated by examiners at Brean Capital. They now have a USD 13 value focus on the stock.
11/11/2015 – Syneron Medical Ltd. had its "purchase" rating repeated by experts at Maxim Group. They now have a USD 14 value focus on the stock.
09/03/2014 – Syneron Medical Ltd. was downsized to "unbiased" by examiners at Zacks. They now have a USD 10.8 value focus on the stock.
01/21/2014 – Syneron Medical Ltd. had its "purchase" rating repeated by experts at Cantor Fitzgerald. They now have a USD 18 value focus on the stock.
11/14/2013 – Syneron Medical Ltd. had its "purchase" rating repeated by investigators at Griffin Securities. They now have a USD 15 value focus on the stock.
The share cost of Syneron Medical Ltd. (NASDAQ:ELOS) was up +0.61% amid the last exchanging session, with a day high of 0.00. 0 shares were exchanged on Syneron Medical Ltd's. last session.
The stock's 50 day moving normal is 7.56 and its 200 day moving normal is 7.19. The stock exchange's capitalization is 284.62M. Syneron Medical Ltd. has a 52-week low of 6.11 and a 52-week high of 8.47.
Syneron Medical Ltd. is occupied with the produce, examine, advancement, advertising and offer of hardware for the stylish medicinal industry and frameworks for dermatologists, plastic specialists and other qualified professionals. The Company plans, creates and advertises tasteful therapeutic items in view of its different advancements, including Electro-Optical Synergy (ELOS) innovation, which utilizes the cooperative energy between electrical vitality, including radiofrequency (RF) vitality, and optical vitality to give stylish medicinal medications. Its items focus on a variety of non-obtrusive tasteful restorative methods, including hair expulsion, wrinkle diminishment, tattoo evacuation, revival of the skin's appearance through the treatment of shallow kind vascular and pigmented injuries, skin break out treatment, treatment of leg veins, treatment for the transitory lessening in the presence of cellulite and thigh circuit, removal and reemerging of the skin, and laser-helped lipolysis.
Get Syneron Medical Ltd. News and Ratings Via Email - Enter your email deliver underneath to get a succinct every day synopsis of the most recent news and investigators' appraisals for Syneron Medical Ltd. with MarketBeat.com's FREE day by day email bulletin.
The latest expert appraisals issued by businesses:
08/05/2016 – Syneron Medical Ltd. was downsized to "market perform" by examiners at Leerink Swann. They now have a USD 7.8 value focus on the stock.
05/31/2016 – Syneron Medical Ltd. had its "purchase" rating repeated by examiners at Brean Capital. They now have a USD 13 value focus on the stock.
11/11/2015 – Syneron Medical Ltd. had its "purchase" rating repeated by experts at Maxim Group. They now have a USD 14 value focus on the stock.
09/03/2014 – Syneron Medical Ltd. was downsized to "unbiased" by examiners at Zacks. They now have a USD 10.8 value focus on the stock.
01/21/2014 – Syneron Medical Ltd. had its "purchase" rating repeated by experts at Cantor Fitzgerald. They now have a USD 18 value focus on the stock.
11/14/2013 – Syneron Medical Ltd. had its "purchase" rating repeated by investigators at Griffin Securities. They now have a USD 15 value focus on the stock.
The share cost of Syneron Medical Ltd. (NASDAQ:ELOS) was up +0.61% amid the last exchanging session, with a day high of 0.00. 0 shares were exchanged on Syneron Medical Ltd's. last session.
The stock's 50 day moving normal is 7.56 and its 200 day moving normal is 7.19. The stock exchange's capitalization is 284.62M. Syneron Medical Ltd. has a 52-week low of 6.11 and a 52-week high of 8.47.
Syneron Medical Ltd. is occupied with the produce, examine, advancement, advertising and offer of hardware for the stylish medicinal industry and frameworks for dermatologists, plastic specialists and other qualified professionals. The Company plans, creates and advertises tasteful therapeutic items in view of its different advancements, including Electro-Optical Synergy (ELOS) innovation, which utilizes the cooperative energy between electrical vitality, including radiofrequency (RF) vitality, and optical vitality to give stylish medicinal medications. Its items focus on a variety of non-obtrusive tasteful restorative methods, including hair expulsion, wrinkle diminishment, tattoo evacuation, revival of the skin's appearance through the treatment of shallow kind vascular and pigmented injuries, skin break out treatment, treatment of leg veins, treatment for the transitory lessening in the presence of cellulite and thigh circuit, removal and reemerging of the skin, and laser-helped lipolysis.
Get Syneron Medical Ltd. News and Ratings Via Email - Enter your email deliver underneath to get a succinct every day synopsis of the most recent news and investigators' appraisals for Syneron Medical Ltd. with MarketBeat.com's FREE day by day email bulletin.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.